These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 4102542)
1. Pregnancy and serum C.P.K. levels in potential carriers of severe X-linked muscular dystrophy. Blyth H; Hughes BP Lancet; 1971 Apr; 1(7704):855-6. PubMed ID: 4102542 [No Abstract] [Full Text] [Related]
2. Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers. Dennis NR; Evans K; Clayton B; Carter CO Br Med J; 1976 Sep; 2(6035):577-9. PubMed ID: 963439 [TBL] [Abstract][Full Text] [Related]
3. Detection of carriers of benign X-linked muscular dystrophy. Emery AE; Clack ER; Simon S; Taylor JL Br Med J; 1967 Dec; 4(5578):522-3. PubMed ID: 6065987 [No Abstract] [Full Text] [Related]
4. Pregnancy and serum-creatine-kinase levels in potential carriers of Duchenne X-linked muscular dystrophy. Emery AE; King B Lancet; 1971 May; 1(7707):1013. PubMed ID: 4102421 [No Abstract] [Full Text] [Related]
5. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Perry TB; Fraser FC Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611 [No Abstract] [Full Text] [Related]
6. The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne. Gardner-Medwin D; Pennington RJ; Walton JN J Neurol Sci; 1971 Aug; 13(4):459-74. PubMed ID: 5570764 [No Abstract] [Full Text] [Related]
7. The effect of pregnancy on serum levels of creatine kinase. King B; Spikesman A; Emery AE Clin Chim Acta; 1972 Jan; 36(1):267-9. PubMed ID: 5007709 [No Abstract] [Full Text] [Related]
8. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy. Skinner R; Emery AE; Anderson AJ; Foxall C J Med Genet; 1975 Jun; 12(2):131-4. PubMed ID: 1142377 [No Abstract] [Full Text] [Related]
9. Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Emery AE Nature; 1977 Mar; 266(5601):472-3. PubMed ID: 859617 [No Abstract] [Full Text] [Related]
10. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study. Zatz M; Frota-Pessoa O; Levy JA; Peres CA J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952 [TBL] [Abstract][Full Text] [Related]
11. [A benign X-chromosomal hereditary muscular dystrophy. I. Examinations of symptom-carriers]. Rotthauwe HW; Kowalewski S Humangenetik; 1966; 3(1):17-29. PubMed ID: 5986051 [No Abstract] [Full Text] [Related]
12. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Hutton EM; Thompson MW Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964 [TBL] [Abstract][Full Text] [Related]
13. X-linked muscular dystrophy, benign form with contractures. McKusick VA Birth Defects Orig Artic Ser; 1971 Feb; 7(2):113-5. PubMed ID: 5173119 [No Abstract] [Full Text] [Related]
14. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy. Zatz M; Passos MR; Bortolini ER Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115 [No Abstract] [Full Text] [Related]
15. The detection of female carriers of pseudohypertrophic muscular dystrophy. Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982 [No Abstract] [Full Text] [Related]
16. The effects of genetic counselling in Duchenne muscular dystrophy. Emery AE; Watt MS; Clack ER Clin Genet; 1972; 3(2):147-50. PubMed ID: 5054316 [No Abstract] [Full Text] [Related]
20. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy. Hetnarska L Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194 [No Abstract] [Full Text] [Related] [Next] [New Search]